Cover Image
市場調查報告書

Gemmus Pharma Inc.的產品平台分析

Gemmus Pharma Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321963
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Gemmus Pharma Inc.的產品平台分析 Gemmus Pharma Inc. - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 21 Pages
簡介

Gemmus Pharma Inc.是總公司設立於美國的藥物研發企業,專門開發流感和其他病毒性疾病的新藥。

本報告提供Gemmus Pharma Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Gemmus Pharma Inc.的基本資料

  • Gemmus Pharma Inc.概要
  • 主要資訊
  • 企業資料

Gemmus Pharma Inc.:R&D概要

  • 主要的治療範圍

Gemmus Pharma Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Gemmus Pharma Inc.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Gemmus Pharma Inc.:藥物簡介

  • GP-1001
  • GP-1002
  • GP-1681

Gemmus Pharma Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Gemmus Pharma Inc.:最新的開發平台資訊

Gemmus Pharma Inc.:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06940CDB

Summary

Global Markets Direct's, 'Gemmus Pharma Inc. - Product Pipeline Review - 2015', provides an overview of the Gemmus Pharma Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Gemmus Pharma Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Gemmus Pharma Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Gemmus Pharma Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Gemmus Pharma Inc.'s pipeline products

Reasons to buy

  • Evaluate Gemmus Pharma Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Gemmus Pharma Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Gemmus Pharma Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Gemmus Pharma Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Gemmus Pharma Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Gemmus Pharma Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Gemmus Pharma Inc. Snapshot
    • Gemmus Pharma Inc. Overview
    • Key Information
    • Key Facts
  • Gemmus Pharma Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Gemmus Pharma Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Gemmus Pharma Inc. - Pipeline Products Glance
    • Gemmus Pharma Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Gemmus Pharma Inc. - Drug Profiles
    • GP-1001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • GP-1002
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • GP-1681
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Gemmus Pharma Inc. - Pipeline Analysis
    • Gemmus Pharma Inc. - Pipeline Products by Target
    • Gemmus Pharma Inc. - Pipeline Products by Route of Administration
    • Gemmus Pharma Inc. - Pipeline Products by Molecule Type
    • Gemmus Pharma Inc. - Pipeline Products by Mechanism of Action
  • Gemmus Pharma Inc. - Recent Pipeline Updates
  • Gemmus Pharma Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Gemmus Pharma Inc., Key Information
  • Gemmus Pharma Inc., Key Facts
  • Gemmus Pharma Inc. - Pipeline by Indication, 2015
  • Gemmus Pharma Inc. - Pipeline by Stage of Development, 2015
  • Gemmus Pharma Inc. - Monotherapy Products in Pipeline, 2015
  • Gemmus Pharma Inc. - Preclinical, 2015
  • Gemmus Pharma Inc. - Pipeline by Target, 2015
  • Gemmus Pharma Inc. - Pipeline by Route of Administration, 2015
  • Gemmus Pharma Inc. - Pipeline by Molecule Type, 2015
  • Gemmus Pharma Inc. - Pipeline Products by Mechanism of Action, 2015
  • Gemmus Pharma Inc. - Recent Pipeline Updates, 2015

List of Figures

  • Gemmus Pharma Inc. - Pipeline by Top 10 Indication, 2015
Back to Top